Martin P - Search Results

1

Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.

Ruan J, Moskowitz A, Mehta-Shah N, Sokol L, Chen Z, Kotlov N, Nos G, Sorokina M, Maksimov V, Sboner A, Sigouros M, van Besien K, Horwitz S, Rutherford SC, Mulvey E, Revuelta MV, Xiang J, Alonso A, Melnick A, Elemento O, Inghirami G, Leonard JP, Cerchietti L, Martin P. Ruan J, et al. Among authors: martin p. Blood. 2023 May 4;141(18):2194-2205. doi: 10.1182/blood.2022018254. Blood. 2023. PMID: 36796016 Free PMC article. Clinical Trial.

2

IL-4 as therapy for non-Hodgkin's lymphoma: possibilities but major challenges.

Martin P, Leonard JP. Martin P, et al. Leuk Lymphoma. 2007 Jul;48(7):1259-60. doi: 10.1080/10428190701416481. Leuk Lymphoma. 2007. PMID: 17613750 No abstract available.

3

Novel therapeutic targets in mantle cell lymphoma.

Martin P, Leonard JP. Martin P, et al. Expert Opin Ther Targets. 2007 Jul;11(7):929-40. doi: 10.1517/14728222.11.7.929. Expert Opin Ther Targets. 2007. PMID: 17614761 Review.

4

Phase I to III trials of anti-B cell therapy in non-Hodgkin's lymphoma.

Martin P, Furman RR, Coleman M, Leonard JP. Martin P, et al. Clin Cancer Res. 2007 Sep 15;13(18 Pt 2):5636s-5642s. doi: 10.1158/1078-0432.CCR-07-1085. Clin Cancer Res. 2007. PMID: 17875800 Review.

5

Targeted therapies for non-Hodgkin lymphoma: rationally designed combinations.

Martin P, Leonard JP. Martin P, et al. Clin Lymphoma Myeloma. 2007 Aug;7 Suppl 5:S192-8. doi: 10.3816/clm.2007.s.022. Clin Lymphoma Myeloma. 2007. PMID: 17877844 Review.

6

Low-dose metronomic, multidrug therapy with the PEP-C oral combination chemotherapy regimen for mantle cell lymphoma.

Coleman M, Martin P, Ruan J, Furman R, Niesvizky R, Elstrom R, George P, Leonard J, Kaufmann T. Coleman M, et al. Among authors: martin p. Leuk Lymphoma. 2008 Mar;49(3):447-50. doi: 10.1080/10428190701837330. Leuk Lymphoma. 2008. PMID: 18297520

7

Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP-C) oral combination chemotherapy regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy.

Coleman M, Martin P, Ruan J, Furman R, Niesvizky R, Elstrom R, George P, Kaufman TP, Leonard JP. Coleman M, et al. Among authors: martin p. Cancer. 2008 May 15;112(10):2228-32. doi: 10.1002/cncr.23422. Cancer. 2008. PMID: 18338745 Free article. Clinical Trial.

8

Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies.

Martin P, Chadburn A, Christos P, Furman R, Ruan J, Joyce MA, Fusco E, Glynn P, Elstrom R, Niesvizky R, Feldman EJ, Shore TB, Schuster MW, Ely S, Knowles DM, Chen-Kiang S, Coleman M, Leonard JP. Martin P, et al. Ann Oncol. 2008 Jul;19(7):1327-1330. doi: 10.1093/annonc/mdn045. Epub 2008 Mar 17. Ann Oncol. 2008. PMID: 18349031 Free article.

9

Novel and engineered anti-B-cell monoclonal antibodies for non-Hodgkin's lymphoma.

Martin P, Furman RR, Ruan J, Elstrom R, Barrientos J, Niesvizky R, Coleman M, Leonard JP. Martin P, et al. Semin Hematol. 2008 Apr;45(2):126-32. doi: 10.1053/j.seminhematol.2008.02.007. Semin Hematol. 2008. PMID: 18381108 Review.

10

FDG-PET in prediction of splenectomy findings in patients with known or suspected lymphoma.

Rutherford SC, Andemariam B, Philips SM, Elstrom RL, Chadburn A, Furman RR, Niesvizky R, Martin P, Fahey TJ, Coleman M, Goldsmith SJ, Leonard JP. Rutherford SC, et al. Among authors: martin p. Leuk Lymphoma. 2008 Apr;49(4):719-26. doi: 10.1080/10428190801927387. Leuk Lymphoma. 2008. PMID: 18398739

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,911 results

Search Page